Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis-Reference-Cited by-同舟云学术

Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis

Published:2022-10-13 Issue:4 Volume:58 Page:403-411
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

He Zhiying¹,Zhou Jialing¹,Tian Yu¹,Wu Shanshan¹,Sun Yameng¹,Ou Xiaojuan¹,Jia Jidong¹,Wang Bingqiong¹,Wu Xiaoning¹,You Hong¹

Affiliation:

1. Liver Research Center, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, National Clinical Research Center for Digestive Disease, Beijing Friendship Hospital, Capital Medical University, Beijing, PR China

Funder

National Science and Technology Major Project

Beijing Municipal Science and Technology Commission

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2022.2132532

Reference27 articles.

1. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016–2021: actions for impact. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.

2. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

3. Liver cirrhosis

4. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies

5. Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis;JHEP Reports;2024-07

2. Liver cirrhosis reversal and recompensation: Existing evidence and future prospects;World Chinese Journal of Digestology;2024-05-28

3. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease;Nature Reviews Gastroenterology & Hepatology;2023-10-05

4. Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding;Hepatology International;2023-09-29

5. Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy;Frontiers in Cellular and Infection Microbiology;2023-01-12